(BIIB) Biogen - Performance -45.6% in 12m
BIIB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-67.66%
#97 in Peer-Group
Rel. Strength
11.57%
#6568 in Stock-Universe
Total Return 12m
-45.60%
#112 in Peer-Group
Total Return 5y
-51.57%
#62 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 12.5 |
| P/E Forward | 8.47 |
| High / Low | USD |
|---|---|
| 52 Week High | 236.80 USD |
| 52 Week Low | 113.38 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 56.11 |
| Buy/Sell Signal +-5 | -0.78 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BIIB (-45.6%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: BIIB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIIB
| Total Return (including Dividends) | BIIB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.02% | 3.18% | 4.52% |
| 3 Months | -7.86% | 2.36% | 10.25% |
| 12 Months | -45.60% | -10.75% | 14.16% |
| 5 Years | -51.57% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | BIIB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -67.9% | 30.9% | 79.1% |
| 3 Months | 45% | 63.2% | 91.7% |
| 12 Months | -96.5% | -83.8% | 44% |
| 5 Years | -61.7% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th38.00 | -7.95% | -9.13% |
| 3 Month | %th41.50 | -9.99% | -16.43% |
| 12 Month | %th44.00 | -39.05% | -52.35% |
| 5 Years | %th69.50 | -35.85% | -77.67% |
FAQs
Does Biogen (BIIB) outperform the market?
No,
over the last 12 months BIIB made -45.60%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months BIIB made -7.86%, while XBI made 2.36%.
Performance Comparison BIIB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BIIB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.4% | -9.5% | -21.2% | -60% |
| US NASDAQ 100 | QQQ | -2% | -10.6% | -22.6% | -60% |
| German DAX 40 | DAX | -2.2% | -5.4% | -36.4% | -76% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.7% | -7.5% | -17.2% | -62% |
| Hongkong Hang Seng | HSI | -1.7% | -11.9% | -38.4% | -81% |
| India NIFTY 50 | INDA | -1.8% | -7.4% | -22.2% | -46% |
| Brasil Bovespa | EWZ | -0.7% | -8.5% | -42.8% | -56% |
BIIB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.6% | -11.9% | -27.5% | -73% |
| Consumer Discretionary | XLY | -0.9% | -6.9% | -13.2% | -66% |
| Consumer Staples | XLP | 2.1% | -3.8% | -20.1% | -54% |
| Energy | XLE | 1.9% | -9.6% | -18.6% | -42% |
| Financial | XLF | -1.1% | -7.5% | -24.4% | -74% |
| Health Care | XLV | -0.3% | -6.7% | -14.5% | -40% |
| Industrial | XLI | -1% | -8.2% | -28% | -69% |
| Materials | XLB | -0% | -7.4% | -22% | -49% |
| Real Estate | XLRE | 3.3% | -4.6% | -19.5% | -57% |
| Technology | XLK | -2.2% | -13.5% | -23.4% | -56% |
| Utilities | XLU | 1% | -6% | -24.9% | -69% |
| Aerospace & Defense | XAR | -3.3% | -14.6% | -42.3% | -98% |
| Biotech | XBI | 0.2% | -8.2% | -8.4% | -35% |
| Homebuilder | XHB | -0% | -8.9% | -10.7% | -46% |
| Retail | XRT | 0.8% | -7.2% | -13.8% | -52% |
BIIB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 5.2% | -14.1% | -14.0% | -35% |
| Natural Gas | UNG | 2.8% | -8.5% | -7.8% | -45% |
| Gold | GLD | 4.2% | -3.6% | -41.2% | -85% |
| Silver | SLV | 2.1% | -12.7% | -39.5% | -67% |
| Copper | CPER | -2.3% | -13.6% | -39.6% | -61% |
BIIB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.4% | -6.8% | -17.4% | -47% |
| iShares High Yield Corp. Bond | HYG | 0.6% | -6.6% | -20.7% | -56% |